{"schema_version":"secwatch.filing_event.v1","accession":"0001356576-25-000065","form_type":"8-K","ticker":"SUPN","cik":"0001356576","company_name":"SUPERNUS PHARMACEUTICALS, INC.","filed_at":"2025-10-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.219693+00:00","generated_at":"2026-05-17T02:59:35.378287+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Supernus schedules Q3 2025 earnings release for Nov 4 after market close","bullets":["Financial results to be released after market close on Tuesday, November 4, 2025.","Conference call at 4:30 p.m. ET with CEO Jack Khattar and CFO Tim Dec.","Live webcast available on Supernus investor relations website; replay for 60 days.","No preliminary financial data provided in this filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001356576-25-000065","json":"https://secwatch.observer/filing/0001356576-25-000065.json","markdown":"https://secwatch.observer/filing/0001356576-25-000065.md","text":"https://secwatch.observer/filing/0001356576-25-000065.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1356576/000135657625000065/0001356576-25-000065-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1356576/000135657625000065/supn-20251021.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:59:35.378287+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}